These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29188761)

  • 1. Metabolic syndrome and cardiovascular risk assessment tools' estimations of 10-year cardiovascular risk: a population-based study.
    Motamed N; Rabiee B; Roozafzai F; Zamani F; Faraji AH; Maadi M; Keyvani H; Khonsari MR; Hemasi GR
    Acta Cardiol; 2018 Oct; 73(5):439-446. PubMed ID: 29188761
    [No Abstract]   [Full Text] [Related]  

  • 2. Framingham risk scores for determination the 10-year risk of cardiovascular disease in participants with and without the metabolic syndrome: results of the Fasa Persian cohort study.
    Dehghan A; Jahangiry L; Khezri R; Jafari A; Pezeshki B; Rezaei F; Aune D
    BMC Endocr Disord; 2024 Jun; 24(1):95. PubMed ID: 38915041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cardiovascular risk assessment tools and their guidelines in evaluation of 10-year CVD risk and preventive recommendations: A population based study.
    Motamed N; Rabiee B; Perumal D; Poustchi H; Miresmail SJ; Farahani B; Maadi M; Saeedian FS; Ajdarkosh H; Khonsari MR; Hemasi GR; Zamani F
    Int J Cardiol; 2017 Feb; 228():52-57. PubMed ID: 27863362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between metabolic syndrome and 10-year risk of developing cardiovascular disease in a Nigerian population.
    Oguoma VM; Nwose EU; Skinner TC; Richards RS; Digban KA; Onyia IC
    Int Health; 2016 Sep; 8(5):354-9. PubMed ID: 27118483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the impact of metabolic syndrome on cardiovascular events vary by using different definitions?
    Khosravi-Boroujeni H; Ahmed F; Sadeghi M; Roohafza H; Talaei M; Dianatkhah M; Pourmogaddas A; Sarrafzadegan N
    BMC Public Health; 2015 Dec; 15():1313. PubMed ID: 26715355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome Components and Long-Term Incidence of Cardiovascular Disease in Eastern Mediterranean Region: A 13-Year Population-Based Cohort Study.
    Mansourian M; Babahajiani M; Jafari-Koshki T; Roohafza H; Sadeghi M; Sarrafzadegan N
    Metab Syndr Relat Disord; 2019 Sep; 17(7):362-366. PubMed ID: 31188051
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential of four definitions of metabolic syndrome to discriminate individuals with different 10-year cardiovascular disease risk scores: a cross-sectional analysis of an Iranian cohort.
    Zibaeenezhad MJ; Sayadi M; Karimi-Akhormeh A; Ardekani A; Parsa N; Razeghian-Jahromi I
    BMJ Open; 2022 Feb; 12(2):e058333. PubMed ID: 35168988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of risk assessment tools for cardiovascular diseases: results of an Iranian cohort study.
    Motamed N; Ajdarkosh H; Perumal D; Ashrafi GH; Maadi M; Safarnezhad Tameshkel F; Farahani B; Rezaie N; Nikkhah M; Faraji AH; Miri SM; Roozafzai F; Khoonsari M; Karbalaie Niya MH; Zamani F
    Public Health; 2021 Nov; 200():116-123. PubMed ID: 34717165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
    Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of coronary heart disease risk assessments among individuals with metabolic syndrome using three diagnostic definitions: a cross-sectional study from China.
    Zhou J; Gao Q; Wang J; Zhang M; Ma J; Wang C; Chen H; Peng X; Hao L
    BMJ Open; 2018 Oct; 8(10):e022974. PubMed ID: 30366915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
    Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
    Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population.
    Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP
    Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
    Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ankle-brachial index testing is particularly indicated in patients with metabolic syndrome but without known arterial disease].
    Schmolling Y; Del Valle FJ; Pérez de Oteyza C; de Lucas A; Brasero F; Fajardo F
    Rev Clin Esp; 2008 Apr; 208(4):175-81. PubMed ID: 18381001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Health Status and Metabolic Syndrome in Adults Living in a Transition European Country: Findings from a Population-Based Study.
    Stojisavljević D; Janković J; Erić M; Marinković J; Janković S
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):568-574. PubMed ID: 29097061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome, glucose tolerance categories and the cardiovascular risk in Spanish population.
    Martínez-Larrad MT; Corbatón-Anchuelo A; Fernández-Pérez C; Lazcano-Redondo Y; Escobar-Jiménez F; Serrano-Ríos M
    Diabetes Res Clin Pract; 2016 Apr; 114():23-31. PubMed ID: 27103365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adapting a Prediction Rule for Metabolic Syndrome Risk Assessment Suitable for Developing Countries.
    Abd El-Wahab EW; Shatat HZ; Charl F
    J Prim Care Community Health; 2019; 10():2150132719882760. PubMed ID: 31662026
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolic syndrome and chronic disease.
    Rao DP; Dai S; Lagacé C; Krewski D
    Chronic Dis Inj Can; 2014 Feb; 34(1):36-45. PubMed ID: 24618380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults.
    Hosseinpanah F; Asghari G; Barzin M; Golkashani HA; Azizi F
    Int J Cardiol; 2013 Sep; 168(1):369-74. PubMed ID: 23041003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.